AEON Biopharma, Inc. Quarterly Operating Lease, Payments in USD from Q3 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
AEON Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2022 to Q4 2024.
  • AEON Biopharma, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $79K.
  • AEON Biopharma, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $319K.
  • AEON Biopharma, Inc. annual Operating Lease, Payments for 2024 was $319K.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $319K $79K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-24
Q3 2024 $80K +$29K +56.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $80K +$54K +208% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $80K +$3K +3.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $51K -$23K -31.1% Jul 22, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $26K Jul 1, 2023 Jul 21, 2023 10-Q 2024-11-13
Q2 2023 $77K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $77K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $74K Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.